Precursor-B cell acute lymphoblastic leukemia (pre-B ALL) is the most common 20 pediatric cancer, but there are no useful zebrafish pre-B ALL models. We describe the first 21 highly-penetrant zebrafish pre-B ALL, driven by human MYC. Leukemias express B 22 lymphoblast-specific genes and are distinct from T cell ALL (T-ALL)-which these fish also 23 develop. Zebrafish pre-B ALL shares in vivo features and expression profiles with human pre-B 24 ALL, and these profiles differ from zebrafish T-ALL or normal B and T cells. These animals 25 also exhibit aberrant lymphocyte development. As the only robust zebrafish pre-B ALL model 26 and only example where T-ALL also develops, this model can reveal differences between MYC-27 driven pre-B vs. T-ALL and be exploited to discover novel pre-B ALL therapies. 28 Statement of significance: We describe the first robust zebrafish pre-B ALL model in MYC-29 transgenic animals known to develop T-ALL, revealing the only animal model with both human 30 ALL types. We also describe aberrant multi-lineage lymphopoiesis. This powerful system can be 31 used to study MYC-driven leukemogenesis and discover new pre-B ALL targeted therapies. 32 33 3
zebrafish models lag behind. A single report of zebrafish B-ALL using transgenic ETV6-RUNX1 48 (19) had low penetrance and long latency (~3% by 1 year), and no subsequent reports with this 49 or any other B-ALL model exist. 50 Here we utilized a cell-specific fluorophore, lck:eGFP (20) , that labels zebrafish B and T cells 51 differentially to discover the first robust D. rerio B-ALL model. Surprisingly, B-ALLs occur in 52 an already-established T-ALL model driven by transgenic human MYC (10), and they are so 53 prevalent that many animals actually have coincident B-and T-ALL. An intensive investigation 54 of this new model using several approaches revealed a number of important findings. First, 55 hMYC-induced B-ALL are pre-B subtype, express immature B cell transcripts, and like human 56 4 pre-B ALL, spread aggressively to lymphoid and non-lymphoid tissues. Second, pre-B ALL 57 express low levels of lck, and thus are dimly-fluorescent in these animals, unlike the brightly- 58 fluorescent T-ALL of this model. Low LCK expression is conserved in human pre-B ALL. 59 Third, in addition to their differential lck:eGFP expression, we report a two-gene classifier that 60 distinguishes pre-B from T-ALL in hMYC fish. Finally, expression profiles of zebrafish pre-B 61 ALL, T-ALL, and normal B and T cells revealed abnormal lymphopoiesis that may underlie the 62 molecular pathogenesis of hMYC-driven ALL. In summary, we report a novel and robust pre-B 63 ALL model, the first in zebrafish. Besides its value for genetic and drug screens, to our 64 knowledge, hMYC fish represent the only animal model that develops both pre-B and T-ALL, 65 providing a unique tool to explore molecular mechanisms of both human ALL types in the same 66 genetic context, or even the same animal.
67
Results: 68 Human MYC induces two zebrafish ALL types with distinct expression signatures 69 Mammalian Myc/MYC transgenes driven by a D. rerio rag2 promoter induce zebrafish T-ALL 70 (6, 10) . To detect and monitor ALL progression, we built double-transgenic fish by crossing 71 Tg(rag2:hMYC) to Tg(lck:eGFP) fish, where a zebrafish lck promoter controls GFP expression 72 (20) . Henceforth, we refer to this double-transgenic line as hMYC;GFP. To study T-ALL in this 73 system, we performed RNA microarray on FACS-purified GFP + ALL cells, analyzing 10 74 hMYC;GFP malignancies and 3 cancers from hlk fish (9), another zebrafish T-ALL model (see 75 Fig. 1A for example animals). 76 Unsupervised analysis divided hlk and hMYC;GFP malignancies precisely, emphasizing 77 fundamental differences in ALL from different D. rerio models (Fig. 1A) . Unexpectedly, 78 hMYC;GFP ALL also clustered into two subgroups with distinct gene expression profiles 79 5 (GEPs). To further investigate these groups, we used hlk T-ALL as a reference and designated 80 the 4 ALL closest to hlk as hMYC-1, and the 6 ALL at the far right as hMYC-2 (blue and orange 81 samples in Fig. 1A ). 82 Separate comparisons of hMYC-1 or hMYC-2 vs. hlk ALL revealed that B cell-specific genes 83 were up-regulated by both types of hMYC;GFP ALL (pax5, btk, cd81, etc.; Fig. 1B) , with 84 hMYC-2 ALL over-expressing additional B cell-specific genes (syk, blnk, ighm) . Ingenuity 85 Pathway Analysis™ (IPA) of these differentially-expressed genes showed enrichment and 86 activation of "PI3K-Signaling in B-Lymphocytes", "B-cell receptor-signaling" and "FcγRIIB-87 signaling in B-cells" pathways by hMYC-2 ALL, but not hMYC-1, relative to hlk T-ALL (data 88 not shown). To further investigate the unanticipated expression of B cell genes by hMYC ALL, 89 we repeated unsupervised analysis using only 14 statistically-significant B cell-specific genes. 90 Remarkably, this signature classified hlk vs. hMYC ALL perfectly and largely reformed both the 91 hMYC-1 and hMYC-2 subclasses (Fig. 1C ).
92
Expression of B cell genes by hMYC cancers was unexpected, because B-ALL has never been 93 described by several laboratories-including ours-that study transgenic Myc/MYC zebrafish (6, 94 10, 11, 15, 18, 21) . Yet microarrays clearly demonstrated B cell genes (ighm, blnk, pax5) were 95 expressed at high, medium, and low levels by hMYC-2, hMYC-1, and hlk ALL, respectively, with 96 T cell-specific itk showing the opposite pattern ( Fig. 1D ). We hypothesized that hMYC-1 and -2 97 cancers might contain different proportions of lymphocytes, with hlk being "pure" T-ALL, but 98 hMYC ALL comprised of varying amounts of T-ALL, B-ALL, and/or B cells. Alternatively, 99 leukemias can express aberrant markers (22), and hMYC might de-differentiate ALL, obscuring 100 cell identities. In either case, B cell genes were high in hMYC-2 and detectable in hMYC-1 also, 101 so we next sought to definitively identify the cellular composition of hMYC cancers. 102 6 B-ALL and T-ALL each occur in hMYC;GFP animals, with different GFP intensities 103 To definitively identify hMYC;GFP ALL as they first developed, we used serial fluorescent 104 microscopy to monitor unaffected animals (i.e., fish lacking visible cancers). In young adults (3-105 6 months), we observed two phenotypes: brightly-fluorescent cancers originating in thymus and 106 dimly-fluorescent cancers with variable thymic involvement (Figs. 1E, S1). To distinguish these, 107 we used "low-exposure" settings that detected only bright cancers [Figs. 1E(a) vs. (c), S1A vs. 108 S1B], and "high-exposure" settings that revealed dim ALL which were otherwise not visible 109 [Figs. 1E(c) vs. (f), S1B vs. S1D]. Dim ALL differed from non-cancerous hMYC and lck:eGFP 110 control animals that showed only normal thymic fluorescence ( Fig. 1F ).
111
Flow cytometric analyses confirmed microscopy findings, with bright and dim ALL showing 112 distinct, >10-fold GFP intensity differences ]. Thus, we could discern ALL with 113 only bright (GFP hi ), only dim (GFP lo ), or both cell populations. We analyzed ALL from 27 114 hMYC fish with fluorescent cancers at 6 months of age and found 7 dim ALL with near-115 exclusively GFP lo cells ( Fig. 2A ) and 14 GFP hi -only ALL (Fig. 2C ). Intriguingly, we also found 116 6 mixed-ALL that contained distinct populations of both GFP hi and GFP lo cells ( Fig. 2B ). 117 Remarkably, these 27 animals developed 33 total ALL, 13 GFP lo and 20 GFP hi . 118 We next tested FACS-purified GFP + dim, bright, or mixed-ALL cells for B cell-(pax5, cd79b, proving lck levels-and thus, cellular fluorescence-distinguish pre-B vs. T-ALL in this model. 150 We also confirmed GFP mRNA and protein levels agree by Western blot (WB), with much 151 higher amounts of total protein needed to detect GFP in pre-B ALL compared to T-ALL ( Fig.   152 3C). 153 lck is generally considered to be T cell-specific (20), but zebrafish NK and myeloid cells also 154 express lck (25, 26) . Pertinent to our study, we analyzed public data from different maturation 155 stages of human lymphocytes (27) and found pre-B cells expressed higher LCK than naïve and 156 mature B cells, although below that of T cells ( Fig. S2A ). Additionally, Microarray Innovations 157 in Leukemia (MILE) data (28) from 1,816 leukemia patients also showed LCK levels in pre-B 158 ALL equal to many T-ALL ( Fig. S2B ). Thus, human and zebrafish pre-B ALL both express 159 LCK/lck. 160 Zebrafish pre-B ALL resembles human pre-B ALL morphologically 161 To examine pre-B ALL histology, we analyzed hMYC fish with dim ALL. Hematoxylin and 162 eosin (H&E) stains showed lymphoblast infiltration of the kidney-marrow, thymus, liver, and 163 elsewhere (Figs. 3D, S3A). Marrow hypertrophy was often profound, with marrow expansion 164 and invasion through muscle into subcutaneous tissue and skin (Fig. S3A, pre-B3, -B4 ). Yet 165 despite these massive disease burdens, fish remained only dimly fluorescent. As in humans, pre-166 B and T-ALL were indistinguishable by H&E ( Fig. S3A-B probe specificity, and showed rare cd79b + B cells, demonstrating few thymic B cells in WT fish. 183 We examined a different animal with disseminated pre-BALL and localized T-ALL, based on 184 microscopy and IHC findings (see microscopy, IHC, and H&E in Fig. S4A , pre-B6), adding a T-185 cell specific probe, lat, to distinguish pre-B vs. T-ALL. RNA ISH demonstrated cells that were 186 hMYC + /cd79b + /lathad completely replaced the marrow and thymic cortex (Fig. 4E) , with GFP hi 187 hMYC + /cd79b -/lat + cells remaining only in an enlarged thymic medulla (i.e., localized T-ALL). 188 Similar results were seen in a second animal with near-complete thymic ablation by pre-B ALL 189 ( Fig. S4C; Fig. 3F , pre-B2 shows microscopy and IHC of this specimen). In summary, in vivo To test whether D. rerio and human pre-B ALL share similar gene expression, we next defined 211 GEPs in a new cohort of animals, quantifying 96 transcripts that distinguish B/T/NK cells, 212 lymphoblasts, and precursor populations (genelist in Table S1) (29, 30). We FACS-purified 8 213 pre-B ALL, 4 T-ALL, and 2 ALL from a mixed-ALL fish ( Fig. 6A-C ; GFP lo or GFP hi 214 populations in orange or blue, respectively), as well as control lymphocytes. For T cell controls, 215 we isolated GFP hi thymocytes from three 10-fish cohorts of control hMYC and lck:GFP fish 216 11 (hMYC thymus-GFP hi , WT thymus-GFP hi ; Fig. 6D ). As another T cell control, we pooled 217 marrow, lymphoid-gated (31) GFP hi cells from these same 30 WT fish (WT marrow-GFP hi ; Fig.   218 6E, blue). hMYC marrow lacked GFP hi cells (Fig. 6F ), so these were not analyzed. For B cells, 219 we purified GFP lo and GFPmarrow cells of the same 3 hMYC control cohorts (hMYC marrow-220 GFP lo , hMYC marrow-GFP -; Fig. 6F ) and from marrow of 30 WT fish used for thymocyte 221 preparations (WT marrow-GFP lo , WT marrow-GFP -; Fig. 6E ). 222 Using barcoded gene-specific probes (Nanostring nCounter™), we quantified mRNA levels of cell GEPs most similar to pre-B ALL (Fig. 7A) . 232 Pre-B and T-ALL GEPs were distinct ( Fig. 7B ; Table S2 lists differentially-expressed genes), 233 with the GFP hi ALL (green) and GFP lo ALL (yellow) of the mixed-ALL animal grouping as T-234 or pre-B ALL, respectively. In total, ~60 homologous genes able to distinguish human (30) and conservation of gene expression between both types of D. rerio and human ALL, we also tested 240 whether human homologues of the differentially-expressed hMYC pre-B-vs. T-ALL genes could 241 reliably classify ALL from the MILE1 study (Fig. 7D ). This signature exhibited remarkable 242 classification power, separating nearly all of these human ALL correctly. Homologues of several 243 other hematopoietic stem/progenitor-or immature lymphocyte-specific genes showed no 244 significant difference between hMYC ALL types (Fig. S5B) . 245 Like ALL, control hMYC and WT thymocytes expressed more rag1 than B cell controls (Fig. 7E,   246 top). From this result, we deduce higher rag1 in zebrafish T-ALL vs. pre-B ALL is unrelated to 247 malignancy, but a normal feature of D. rerio lymphoblasts, although different from mammals. 248 Notably, hMYC B cell controls showed higher rag2 than WT B cells, implying hMYC may 249 expand the pre-B cell population (Fig. 7E, bottom) . We also analyzed Ig heavy chain expression.
250 Surprisingly, pre-B ALL expressed only ighz (Fig. 7F) , an isotype unique to teleost fish that is 251 functionally analogous to mammalian IgA (32). GFP lo hMYC B cells expressed ighm (Fig. 7G,   252 left), so ighm + pre-B ALL should be detectable in hMYC fish-but these were not found. 253 Therefore, MYC may be oncogenic in only the ighz-lineage. Another B-lineage abnormality we 254 noted is that hMYC GFP lo cells lacked ighd (Fig. 7G, right) , so hMYC may suppress ighd 255 transcription or repress this lineage, just as it seems to block the T cell lineage in hMYC marrow 256 (Fig. 6F) . Overall, hMYC dramatically perturbs zebrafish B cell development, inducing ALL in 257 ighz + B cells, and skewing both the ighm and ighd lineages. 258 Finally, we found substantially higher lmo2 in normal and malignant B vs. T cells (Fig. 7H) , 259 mirroring LMO2 findings in human B vs. T cells (33), which we independently confirmed in 260 public human B and T cell data (Fig. S5C) . This contradicts the assertion that MYC-driven 261 zebrafish T-ALL emulates the human TAL1/LMO subtype (6). Instead, hMYC T-ALL actually 262 13 had the lowest lmo2 levels of the 9 populations that were tested, including all T cell controls 263 (Fig. 7H ).
264
Discussion: 265 Pre-B ALL is the most common pediatric cancer and kills more children than any other type (3), 266 but no good zebrafish models exist for this important disease. Drug screens (17, 18) , genetic 267 studies (11, 12, 15) and stem cell discoveries (13, 14) (Figs. 1E, 2-7 , S1, S4). Consequently, even in 277 fish with concomitant pre-B and T-ALL-which we believe are unique to this model-these cell 278 lineages and ALL types, can be reliably separated for independent study. 279 Apart from the utility of lck:GFP in this system, hMYC pre-B ALL are powerful because they 280 emulate this human disease in several ways: histology and organ involvement ( Figs. 3-4, S3-4) , 281 lck levels ( Fig. S2) and, most importantly, gene expression signature (Fig. 7) . In fact, genes that 282 differentiate zebrafish pre-B vs. T-ALL (Fig. 7B ) classify human ALL also (Fig. 7D) . The GEPs 283 we obtained revealed many transcripts that distinguish pre-B vs. T-ALL in this model, but we 284 14 also report a two-gene panel to categorize hMYC ALL that requires only igic1s1 and rag1, and 285 this panel can be applied to any hMYC genetic background. 286 Interestingly, although RAG1 is expressed by mammalian B-and T-lymphoblasts, we find that 287 only D. rerio T-lymphoblasts express rag1 highly, with levels >70-and >155-fold greater in 288 normal T or T-ALL cells than in B or pre-B ALL cells, respectively (Figs. 3A(e) and T-ALL, and not biphenotypic ALL. Certainly, because hMYC can induce both ALL types, it 294 remains possible that mixed-lineage biphenotypic ALL may arise in this system, but to date, our 295 analyses of >40 dim ALL have failed to detect any that express T cell genes, suggesting that 296 GFP lo ALL are always B-lineage, and GFP hi always represent T-ALL. In future work, studying 297 both ALL types in one background-or one animal-presents new opportunities, like efforts to 298 find cooperating genetic lesions unique to one type of ALL, lymphocyte lineage-specific drugs, 299 or myriad other applications. 300 Our results also demonstrate multiple features of abnormal B and T lymphopoiesis in hMYC fish. 301 Of interest, pre-B ALL GEPs closely matched the gene expression pattern of a recently-302 described ighz + B cell population dubbed "fraction 2" (34), suggesting hMYC is oncogenically 303 active in this cell population. Supporting this, every pre-B ALL we identified was ighz + (Fig.   304 7F). Liu et al. postulated that the zebrafish ighm-lineage lacks a classic pre-B stage. If this is 305 correct, it is logical that pre-B ALL only occurs in ighz + cells, the lineage that has pre-B cells. 306 We note that ighm + cells do express lck (Fig. 7G) , so ighm + pre-B ALL should be GFP + and 307 15 detectable in this system. Yet ighm + pre-B ALL were never detected, so we conclude they do not 308 occur. In addition to our finding that ALL develops in only ighz + cells, we also found that hMYC 309 alters other B-lineages, with ighm and ighd both reduced in hMYC marrow ( Fig 7G) . Whether 310 this is due to ighm and ighd transcriptional-or lineage-repression remains to be determined. 311 Notably, T cells are also diminished in hMYC marrow (Fig. 6F) , so hMYC alters both the B and 312 T lymphocyte lineages, beyond inducing both pre-B and T-ALL. 313 Clearly, hMYC is leukemogenic to lymphocytes and perturbs zebrafish lymphocyte development. 314 In future work, hMYC pre-B ALL can be used for classic zebrafish approaches like chemical and 315 genetic screens, or in mechanistic studies probing hMYC biology in either ALL type. MYC is 316 arguably the most clinically-relevant oncogene, important in many cancers besides ALL (35) 
